These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 9765767)

  • 21. Mirtazapine versus megestrol acetate in treatment of anorexia-cachexia in advanced cancer patients: a randomized, double-blind trial.
    Chowdhury IH; Rahman MS; Chowdhury MNK; Afroze YJ; Tabassum M; Marnush M; Zerin N
    Jpn J Clin Oncol; 2024 May; 54(5):530-536. PubMed ID: 38323684
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Report of a pilot, double-blind, placebo-controlled study of megestrol acetate in elderly dialysis patients with cachexia.
    Yeh SS; Marandi M; Thode HC; Levine DM; Parker T; Dixon T; Schuster MW
    J Ren Nutr; 2010 Jan; 20(1):52-62. PubMed ID: 19819724
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Phase II trial evaluating the effect of megestrol acetate-prednisolone combination in the treatment of anorexia during the palliative-care phase of lung cancer].
    Jeanfaivre T; Souday V; Chaleil D; Maillet F; Tuchais E
    Rev Pneumol Clin; 2000 Sep; 56(4):255-60. PubMed ID: 11033533
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Low doses of megestrol acetate increase weight and improve nutrition status in patients with severe chronic obstructive pulmonary disease and weight loss].
    Herrejón A; Palop J; Inchaurraga I; López A; Bañuls C; Hernández A; Blanquer R; Están N; Anguera A
    Med Clin (Barc); 2011 Jul; 137(5):193-8. PubMed ID: 21524765
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A controlled trial of megestrol acetate on appetite, caloric intake, nutritional status, and other symptoms in patients with advanced cancer.
    Bruera E; Macmillan K; Kuehn N; Hanson J; MacDonald RN
    Cancer; 1990 Sep; 66(6):1279-82. PubMed ID: 2205358
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Supportive treatment in weight-losing cancer patients due to the additive adverse effects of radiation treatment and/or chemotherapy.
    Erkurt E; Erkisi M; Tunali C
    J Exp Clin Cancer Res; 2000 Dec; 19(4):431-9. PubMed ID: 11277319
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Megestrol acetate for anorexia in patients with far-advanced cancer: a double-blind controlled clinical trial.
    De Conno F; Martini C; Zecca E; Balzarini A; Venturino P; Groff L; Caraceni A
    Eur J Cancer; 1998 Oct; 34(11):1705-9. PubMed ID: 9893656
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A retrospective study of the association between megestrol acetate administration and mortality among nursing home residents with clinically significant weight loss.
    Bodenner D; Spencer T; Riggs AT; Redman C; Strunk B; Hughes T
    Am J Geriatr Pharmacother; 2007 Jun; 5(2):137-46. PubMed ID: 17719516
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A randomized, double-blind, 8-week crossover study of once-daily controlled-release tramadol versus immediate-release tramadol taken as needed for chronic noncancer pain.
    Beaulieu AD; Peloso P; Bensen W; Clark AJ; Watson CP; Gardner-Nix J; Thomson G; Piraino PS; Eisenhoffer J; Harsanyi Z; Darke AC
    Clin Ther; 2007 Jan; 29(1):49-60. PubMed ID: 17379046
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Patient-controlled methylphenidate for cancer fatigue: a double-blind, randomized, placebo-controlled trial.
    Bruera E; Valero V; Driver L; Shen L; Willey J; Zhang T; Palmer JL
    J Clin Oncol; 2006 May; 24(13):2073-8. PubMed ID: 16648508
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Usage of megestrol acetate in the treatment of anorexia-cachexia syndrome in the elderly.
    Yeh SS; Lovitt S; Schuster MW
    J Nutr Health Aging; 2009 May; 13(5):448-54. PubMed ID: 19390752
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R
    Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Value of megestrol acetate in treatment of cachexia in head-neck tumors].
    Büntzel J; Küttner K
    Laryngorhinootologie; 1995 Aug; 74(8):504-7. PubMed ID: 7575903
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects by daily long term provision of ghrelin to unselected weight-losing cancer patients: a randomized double-blind study.
    Lundholm K; Gunnebo L; Körner U; Iresjö BM; Engström C; Hyltander A; Smedh U; Bosaeus I
    Cancer; 2010 Apr; 116(8):2044-52. PubMed ID: 20186829
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Randomised phase III clinical trial of 5 different arms of treatment on 332 patients with cancer cachexia.
    Mantovani G
    Eur Rev Med Pharmacol Sci; 2010 Apr; 14(4):292-301. PubMed ID: 20496538
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transdermal buprenorphine patches applied in a 4-day regimen versus a 3-day regimen: a single-site, Phase III, randomized, open-label, crossover comparison.
    Likar R; Lorenz V; Korak-Leiter M; Kager I; Sittl R
    Clin Ther; 2007 Aug; 29(8):1591-606. PubMed ID: 17919542
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Double-blind, placebo-controlled, randomized study of eicosapentaenoic acid diester in patients with cancer cachexia.
    Fearon KC; Barber MD; Moses AG; Ahmedzai SH; Taylor GS; Tisdale MJ; Murray GD
    J Clin Oncol; 2006 Jul; 24(21):3401-7. PubMed ID: 16849754
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Randomized comparison of megestrol acetate versus dexamethasone versus fluoxymesterone for the treatment of cancer anorexia/cachexia.
    Loprinzi CL; Kugler JW; Sloan JA; Mailliard JA; Krook JE; Wilwerding MB; Rowland KM; Camoriano JK; Novotny PJ; Christensen BJ
    J Clin Oncol; 1999 Oct; 17(10):3299-306. PubMed ID: 10506633
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Megestrol acetate in pediatric oncology patients may lead to severe, symptomatic adrenal suppression.
    Orme LM; Bond JD; Humphrey MS; Zacharin MR; Downie PA; Jamsen KM; Mitchell SL; Robinson JM; Grapsas NA; Ashley DM
    Cancer; 2003 Jul; 98(2):397-405. PubMed ID: 12872362
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Megestrol acetate and mirtazapine for the treatment of unplanned weight loss in the elderly.
    Fox CB; Treadway AK; Blaszczyk AT; Sleeper RB
    Pharmacotherapy; 2009 Apr; 29(4):383-97. PubMed ID: 19323618
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.